(Q47600090)

English

Imatinib mesylate (gleevec) hepatotoxicity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

Imatinib mesylate (gleevec) hepatotoxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ayse L Mindikoglu

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

Arie Regev

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

Pablo A Bejarano

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

Enrique J Martinez

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

Lennox J Jeffers

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

Eugene R Schiff

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

publication date

12 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

52

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

598-601

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

https://scigraph.springernature.com/pub.10.1007/s10620-006-9117-1

0 references

Imatinib (Gleevec)-induced hepatotoxicity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe hepatitis and complete molecular response caused by imatinib mesylate: possible association of its serum concentration with clinical outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indications for imatinib mesylate therapy and clinical management

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal hepatic necrosis following imatinib mesylate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histological features of acute hepatitis after imatinib mesylate treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17219077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-006-9117-1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/17219077

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47600090&oldid=2161873850"